Midpregnancy serum thromboxane B2 determinations do not predict subsequent adverse pregnancy outcomes

Am J Obstet Gynecol. 1993 Jul;169(1):105-6. doi: 10.1016/0002-9378(93)90140-e.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Female
  • Fetal Growth Retardation / blood
  • Humans
  • Hypertension / blood
  • Pre-Eclampsia / blood
  • Pregnancy
  • Pregnancy Complications / blood*
  • Pregnancy Outcome*
  • Thromboxane B2 / blood*

Substances

  • Thromboxane B2